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This review describes target-enrichment approaches followed by next generation
sequencing and their recent application to the research and diagnostic field of modern
and past infectious human diseases caused by viruses, bacteria, parasites and fungi.
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INTRODUCTION
The development of next-generation sequencing (NGS) approaches has revolutionized human
clinical research because of its ability to rapidly generate large volumes of sequencing data
per run, with a concomitant decrease of sequencing costs (Shendure and Ji, 2008). Unbiased
ultra-deep sequencing of complex samples is now accessible, although bioinformatics analyses
may still be long and tedious. This issue is particularly problematic in the field of infectious
disease diagnostic, where the rapid identification and functional characterization of a particular
pathogen is critical for the clinical management of infected patients. So far, polymerase chain
reaction (PCR) has been the gold standard method for the clinical diagnosis of infectious diseases
(Edwards and Gibbs, 1994). This approach, which is based on the amplification of a generally
short and conserved genomic region, can provide information on the presence/absence and
abundance of a targeted microbial pathogen. PCR has numerous advantages, such as low cost,
rapid processing and results acquisition, automation, sensitivity and specificity. However, and
precisely because of its high specificity, PCR may not detect microorganisms whose sequences
are too divergent from those targeted by the primers and probes designed. In addition, PCR will
provide only partial information on the genetic diversity, genotype, functional potential, nutritional
requirements as well as virulence or antibiotic-resistance. Such information, that could only be
retrieved from whole genome sequencing (WGS), usually requires culture of the pathogen, which
can be unsuccessful in the majority of cases (and particularly for viruses and other intracellular
organisms which need host cells), can take several weeks for fastidious microorganisms or can
be prevented by early administration of antimicrobial drugs. The power of NGS might thus be
of particular interest in that cases for reconstructing full genomes of pathogens directly from
nucleic acids extracted from clinical samples. However, due to the low pathogen/nucleic acid
ratio in these complex biological samples, NGS may fail to detect/reconstruct genomes from
pathogens present in low copy numbers in the sample. To overcome these limitations, capture
methods, such as hybridization capture followed by NGS sequencing (also called hybrid-capture
sequencing or target-enrichment sequencing) applied directly on human clinical samples have been
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developed (Mamanova et al., 2010). These approaches allow
retrieving large genomic fragments to complete genomes
with high sequencing coverage, which facilitate downstream
investigations, such as phylogenetics, evolution, epidemiology,
and drug resistance. In this review, we will briefly describe the
different principles of hybridization capture coupled with NGS,
its early developments on human genetic studies and applications
in the recent years to the study of present and past human
infectious diseases (Gasc et al., 2016) directly from biological
samples.
OVERVIEW OF THE EXPERIMENTAL
PROCEDURE AND APPLICATIONS
Next-generation sequencing hybridization-based capture is
an approach directly applied after nucleic acid extraction and
library preparation (Figure 1). Fragmented shotgun libraries
are denatured by heating and subjected to hybridization with
DNA or RNA single-stranded oligonucleotides (called also
‘probes’ or ‘baits’) specific to the region of interest (Kozarewa
et al., 2015). RNA baits are preferable, because RNA:DNA
duplexes are better in term of hybridization efficiency and
stability, compared to DNA:DNA hybrids (Lesnik and Freier,
1995). Non-specific unbound molecules are washed away,
and the enriched DNA is eluted for NGS (Kozarewa et al.,
2015). The hybridization between DNA libraries and baits
FIGURE 1 | Overview of target-enrichment sequencing procedure and its
application to research and diagnostic infectiology.
can be carried out in solution or on a solid support. In
“solid-phase,” DNA probes are bound to a solid support,
such as a glass microarray slide (Albert et al., 2007; Okou
et al., 2007), where in “solution-capture,” free DNA or RNA
probes are biotinylated allowing them to isolate the targeted
fragment-probe heteroduplexes using magnetic streptavidin
beads (Gnirke et al., 2009). So far, there is no standardize
protocol for target enrichment processes and several adjustments
can be made on library fragment size, sample fragmentation,
cleanup procedures, number of PCR amplification cycles,
and/or the hybridization duration. Detailed protocols are
described in the work of Mamanova et al. (2010) along with
values on specificity, sensitivity and reproducibility of each
tested procedure. The ultimate step of NGS hybridization-based
capture is the sequencing of the enriched nucleic acids and
bioinformatic analyses of the reads. The last process usually
includes steps of trimming (for adapter sequences, low quality
and duplicate reads), mapping of the remaining reads on
reference genomes for pathogen detection and identification,
and/or assembly into contigs for genome reconstruction
(Figure 1). The information provided by the genome can
further be explored to investigate the genetic diversity (strain
genotyping, variant detection), epidemiology, evolutionary
history, transmission networks, and/or antimicrobial resistance
of the target pathogen(s).
EARLY DEVELOPMENTS OF
HYBRID-CAPTURE STRATEGIES:
HUMAN GENETIC STUDIES ON
MODERN AND ANCIENT SAMPLES
Target-enrichment strategy using hybrid capture was originally
developed for human genomic studies for which it was used to
capture and sequence the entire human exome. This genomic
technique, also called exome sequencing (or whole exome
sequencing) was first applied by using an array-based hybrid
capture method in 2007 (Hodges et al., 2007). In this study,
the authors developed six customized NimbleGen arrays to
capture about 180,000 coding exons with overlapping 60–
90-nt probes allowing an average enrichment of exon DNA
sequences of 323 folds. Whole exome sequencing using capture
arrays has proven its usefulness in identifying rare variants
and mutations causing disease (Choi et al., 2009; Ng et al.,
2009). The limitations of this technique include the need to
design an array and a relatively large amount of DNA. To
overcome some of the weaknesses of the previous method,
Gnirke et al. (2009) have developed an in-solution hybrid
capture method for human whole exome sequencing. To
do so, biotinylated RNA baits of 170 bases in length were
constructed, targeting 5,565 human protein-coding exons. In
this study, authors have demonstrated the possibility to perform
hybrid selection in solution. Following this, many targeted
human exome in-solution enrichment methods for NGS have
been developed, including those commercialized by Illumina1
1www.illumina.com
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and Agilent Genomics2 (Chen et al., 2015a,b). In-solution
capture for exome sequencing turned out to be an effective
approach applied to discover the causal mutation of rare
Mendelian disorders (Shearer et al., 2010; Martignetti et al.,
2013; Nectoux et al., 2015; Rousseau-Nepton et al., 2015),
of complex disorders (Poultney et al., 2013; Guipponi et al.,
2014; Griesi-Oliveira et al., 2015; Pérez-Serra et al., 2015),
mitochondrial disorders (Calvo et al., 2012; Gai et al., 2013)
and more recently of the screening of potential genetic mutation
of patients suffering from cancer (Sikkema-Raddatz et al.,
2013; Drilon et al., 2015; Xie et al., 2016; Rozenblum et al.,
2017; Xu et al., 2017; Clark T.A. et al., 2018; Schrock et al.,
2018).
The power of hybridization capture has been also successfully
used to study human ancient DNA (aDNA) preserved in ancient
human remains. Indeed, in ancient human samples, DNA is
highly fragmented (thus a shotgun fragmentation step is usually
not required) and dominated by a large contamination of
environmental and bacterial DNA, which poses a limitation in
shotgun aDNA sequencing experiment (Knapp and Hofreiter,
2010). Another characteristic of aDNA is cytosine deamination
on the ends of DNA fragments. Library construction can be
done directly on the double stranded DNAs (dsDNAs) or single
stranded DNAs (ssDNAs) and may include cytosine deamination
removal by the use of a damage treatment step with uracil
DNA glycosylase and/or endonuclease VIII (Briggs et al., 2010).
The first genetic marker analyzed in human paleogenetic studies
was mitochondrial DNA (mtDNA) because of its higher copy
number in the cell than nuclear DNA. Probe hybridization
assays used biotinylated DNA or RNA probes targeting the
two hypervariable segments of the mtDNA control region (CR)
(Briggs et al., 2009; Krause et al., 2010; Maricic et al., 2010;
Enk et al., 2013; Kihana et al., 2013; Templeton et al., 2013;
Eduardoff et al., 2017; Loreille et al., 2018). Another uniparental
marker, the Y-chromosome DNA (Y-DNA), was also used to
study aDNA. As each cell possesses only one copy of the Y
chromosome, the hybridization capture was carried out to enrich
specific genomic regions of the Y chromosome both on solid
support (Fu et al., 2013) and in solution (Cruz Dávalos et al.,
2017). However, targeting mitochondrial DNA or Y chromosome
involves discarding a large proportion of potentially informative
sequences present in autosomal DNA. For this reason, Carpenter
et al. (2013) reported a new capture-based method, called whole-
genome in-solution capture (WISC), using modern DNA as
bait covering the entire human genome. This method was
applied to 12 ancient human DNA libraries and showed an
enrichment of 6 to 159 folds of the sequence mapping to the
human genome with enrichments of 2 to 13 folds for unique
fragments (Carpenter et al., 2013). As for modern human genetic
studies, commercial kits targeting mitochondrial DNA, custom
loci, or entire nuclear genomes, such as those developed by
Arbor Bioscience (myBaits R©3) are now employed in the genetic
sequencing of ancient DNA (Enk et al., 2014; Lindo et al.,
2017).
2www.genomics.agilent.com
3http://www.arborbiosci.com
APPLICATIONS OF
TARGET-ENRICHMENT SEQUENCING
TO HUMAN INFECTIOUS DISEASES
Parasites and Fungi
The first application of hybrid selection method for
infectious diseases was in the field of human parasitology
research(Melnikov et al., 2011; Table 1). To overcome the low
proportion of Plasmodium falciparum sequences relative to that
of their human host, authors have proposed to adapt in-solution
NGS hybrid capture method to enrich this pathogen. This
protocol has been tested in both mock mixtures composed of
99% human DNA and 1% Plasmodium but also in P. falciparum
clinical samples. For this purpose, synthetic 140 bp oligos labeled
with biotin were designed to capture exonic regions of the
P. falciparum genome, whereas 250 bp oligos were constructed
to target the entire genome. Processed and unprocessed samples
were then sequenced with an Illumina technology. In the
mockmetagenome, sequencing of the hybrid-selected samples
yielded between 37 to 44-fold enrichment of the parasite DNA.
In the human clinical sample, Illumina sequencing showed
that at least 5.9% of reads mapped to Plasmodium, but no
data was provided regarding the percentage of Plasmodium
reads obtained without hybrid capture (Melnikov et al., 2011).
However, this first study highlighted the good performance
of NGS hybrid capture to sequence parasite genome from
human clinical samples. In 2012, other studies confirmed the
good performance of in-solution hybrid capture to enrich
P. falciparum (Smith et al., 2012) sequences and P. vivax (Bright
et al., 2012).
Fungi are also a major cause of human diseases that can
be particularly serious in immunocompromized patients or in
patients hospitalized for serious diseases (Pfaller and Diekema,
2010). For example, systemic infections with Candida albicans in
immunocompromized patients result in mortality rates of about
50% (Pfaller and Diekema, 2010). The prevention, diagnosis
and therapy of fungi infections remain very difficult and
comprehension of transcriptional regulation between fungal
pathogens and host is an important step to identify potential
novel targets for drug development (Pfaller and Diekema, 2010).
Again, the limitations of host and pathogen transcriptome
analysis lie in the low proportion of fungal RNA present
in the total extracted RNA. The use of specific enrichment
procedures before RNASeq analysis has then been proposed as an
alternative method to overcome the problem of low fungus/host
RNA ratio. For this purpose, Amorim-Vaz et al. (2015) have
designed a set of 55,342 biotinylated 120 bp-RNA probes covering
6,094 C. albicans ORFs. cDNA libraries were established using
SureSelect (Agilent) after extraction of RNA from mice kidney
or Galleria mellonella larvae infected with C. albicans, and were
subjected to capture with biotinylated probes before Illumina
HiSeq sequencing. Results showed up to a 1670-fold enrichment
of C. albicans reads in a given biological sample and a detection
of more than 86% of its genes. Many genes that have been
regulated in in vivo infection experiments have functions that
have not yet been characterized and will require further research
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TABLE 1 | Example of studies that used target-enrichment sequencing for parasitic, fungal, bacterial, or viral diseases in modern and ancient samples.
Targeted organism Probes design Infectious
disease
Sample tested Methods Nucleic acids Sequencing Reference
Parasitic and fungal disease
Plasmodium falciparum
3D7
Whole genome Malaria Mock sample
whole blood
In-solution DNA Illumina GAIIx
Illumina HiSeq
Melnikov et al.,
2011
P. falciparum 3D7 Whole genome Malaria Mock sample
Whole blood
In-solution DNA Illumina GAIIx Smith et al.,
2012
Plasmodium vivax Whole genome Malaria Whole blood In-solution DNA Illumina HiSeq Bright et al.,
2012
Candida albicans 6094 ORFS Systemic
candidiasis
Animal model of
infection
In-solution RNA (cDNA) Illumina HiSeq Amorim-Vaz
et al., 2015
Bacterial disease
Chlamydia trachomatis 74 References
whole genome
Trachoma Vaginal swabs
Urine
In-solution DNA Illumina MiSeq Christiansen
et al., 2014
Mycobacterium
tuberculosis H37Rv
Whole genome Multidrug-
resistant
tuberculosis
Sputum In-solution DNA Illumina MiSeq Brown et al.,
2015
Neisseria meningitidis 77 Complete
reference genome
and 2898 drafts
Invasive
meningococcal
disease
CSF Whole blood In-solution DNA Illumina MiSeq Clark S.A.
et al., 2018
Viral disease
Varicella-zoster virus
Epstein–Barr virus
Kaposi’s
Sarcoma-Associated
Herpesvirus
Whole genome Zoster-vaccine
rash, wild-type
zoster,
encephalitis
Clinical and
cultured samples
In-solution DNA Illumina GAIIx Depledge et al.,
2011
Merkel cell
polyomavirus (MCPyV)
23 Overlapping
PCR products that
tiled across the
MCPyV genome
Merkel cell
carcinoma
Formalin-Fixed,
Paraffin-Embedded
Tissue
In-solution DNA Illumina GAIIx Duncavage
et al., 2011
Human Herpesvirus 7
(HHV7)
Whole genome Exanthem
subitum
Cellular culture In-solution DNA Illumina MiSeq Donaldson
et al., 2013
Epstein–Barr Virus
(EBV)
Whole genome Nasopharyngeal
carcinoma
(NPC)
NPC tumor biopsy In-solution DNA Illumina MiSeq Kwok et al.,
2014
Zika virus (ZIKV) Whole genome ZIKV infection Blood, urine,
cerebrospinal fluid,
and saliva
In-solution RNA (cDNA) Illumina HiSeq Metsky et al.,
2017
Lassa virus 2 References
complete genome
Hemorrhagic
fevers
Plasma or serum In-solution RNA (cDNA) Illumina HiSeq Matranga et al.,
2014
Varicella Zoster Virus
(VZV)
Whole genome Vaccine-
associated
rashes
Vesicular fluid In-solution DNA Illumina (GAIIx,
HiSeq, and
MiSeq)
Depledge et al.,
2014
ViroCap 337 DNA and
RNA viral species
infecting human and
animals
1456 RefSeq +
genome neighbor
sequences
(185,835 fasta total)
n.a. Panel of human
samples
In-solution DNA and RNA
(cDNA)
Illumina HiSeq Wylie et al.,
2015
VirCapSeq-VERT 207
viral taxa infecting
vertebrates
342,438 Coding
sequences
(1,993,200
oligonucleotide
probes)
n.a. Mock samples
Human clinical
samples and animal
samples
In-solution DNA and RNA
(cDNA)
Illumina HiSeq Briese et al.,
2015
Norovirus 662 References
complete or partial
genome
Acute
gastroenteritis
Stool suspensions In-solution RNA (cDNA) Illumina MiSeq Brown et al.,
2016
(Continued)
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TABLE 1 | Continued
Targeted
organism
Probes design Infectious
disease
Sample tested Methods Nucleic acids Sequencing Reference
Hepatitis C
Virus (HCV)
953 Reference
complete
genomes
HCV infections Plasma Mock
samples RNA
transcripts
In-solution RNA (cDNA) Illumina MiSeq Thomson et al.,
2016
Exogenous
retroviruses
Immunodeficiency
virus type-1
(HIV-1) and the
human T-cell
leukemia virus
type-1 (HTLV-1)
Whole genome n.a. Infected cells In-solution DNA Illumina MiSeq Miyazato et al.,
2016
Herpes simplex
virus 1 and 2
(HSV-1/HSV-2)
Whole genome Skin rash,
herpetic lesions
Swab of the
lesion
In-solution DNA Illumina MiSeq Greninger et al.,
2018
ViroFind 535
DNA and RNA
viral species
that are known
to infect
humans
Whole genome Progressive
multifocal
leukoencephalopathy
(PML)
˙˙Post mortem
PML brain
samples
In-solution DNA and RNA
(cDNA)
Illumina MiSeq Chalkias et al.,
2018
Infectious diseases in paleomicrobiology
Yersinia pestis
strain CO92
Whole genome
or pCD1 and
pMT1 plasmids
Plague (Black
Death)
1347–1351
Teeth Microarray DNA Illumina GAIIx Bos et al., 2011
Y. pestis strain
CO92
Portion of the
Y. pestis
pPCP1 plasmid
Plague (Black
Death)
1347–1351
Bones and
Teeth
In-solution DNA Illumina GAIIx Schuenemann
et al., 2011
Y. pestis strain
CO92
Core genome,
plasmids and
155 other
genes
Plague
(Justinian)
(6–8th
centuries)
Teeth In-solution DNA Illumina HiSeq Wagner et al.,
2014
Mycobacterium
tuberculosis
rpoB, gyrA,
gyrB, katG, and
mpt40 genes
Tuberculosis
(1000 year old)
Skeletal
samples
In-solution DNA Illumina HiSeq Bos et al., 2014
Mycobacterium
leprae
3 Genomic loci Leprosy (11th
to 14th century)
Bones and
teeth
In-solution DNA Illumina MiSeq
and HiSeq
Schuenemann
et al., 2013
Variola virus Whole genome Smallpox
(1643–1665)
Mummified
tissues of a
child
In-solution DNA Illumina HiSeq Duggan et al.,
2016
P. falciparum Mitochondrial
genomes of
Plasmodium
spp.
Malaria
(1st–2nd
century)
Teeth In-solution DNA Illumina HiSeq Marciniak et al.,
2016
Treponema
pallidum
Whole genome Syphilis (1681
to 1861)
Bones Microarray DNA Illumina HiSeq Schuenemann
et al., 2018
n.a., not applicable.
to understand their role during infection (Amorim-Vaz et al.,
2015).
Bacteria
In bacteriological research and diagnostic, targeted capture
strategies prior to sequencing could be a powerful tool in the
management and therapeutics of patients with infectious disease.
Indeed, the rapid identification of antimicrobial resistance
is essential for a rapid and effective treatment. Regarding
Mycobacterium tuberculosis, current methods of screening for
antimicrobial resistance, which are based on the culture of the
organism from sputum samples before sequencing, can take up
to several weeks. To overcome these limitations, Brown et al.
have proposed to use oligonucleotide enrichment technology to
capture M. tuberculosis genome sequences directly from positive
smear sputum samples (Brown et al., 2015; Table 1). Whole
genome baits (120-mer RNA baits) were designed to span the
entire positive strand of the H37Rv M. tuberculosis reference
genome and synthesized by Agilent Technologies. The authors
demonstrated the reliability of targeted sequencing to recover and
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sequence, in less than 96 h, nearly complete genomes directly
from 81% (21/26) smear positive sputa but also its robustness
to identify the genotype and resistance determinants of all
samples that were previously tested positive samples. This study
emphasizes the use of hybrid selection target enrichment that
could allow personalized antimicrobial treatment in multidrug-
resistant tuberculosis (Brown et al., 2015). Other studies have
used biotinylated baits spanning entire genomes for high-
resolution strain genotyping directly from clinical samples.
Indeed, discrimination of Chlamydia trachomatis serovars from
genital samples would facilitate the study of population structures
and modes of transmission (Christiansen et al., 2014) while
genomic data from uncultured Neisseria meningitidis not grown
in the case of invasive meningococcal would allow increased
surveillance of vaccine antigens and studies on possible vaccine
deficiencies (Clark S.A. et al., 2018).
Viruses
In viral research and diagnostic laboratories, viral WGS is also
essential for the detection of drug resistance and the development
of novel treatments and vaccines (Houldcroft et al., 2017). In
this domain, the first study that demonstrated the effectiveness
of target capture technology for reconstructing full herpesvirus
genomes from complex biological samples was proposed by
Depledge et al. (2011) (Table 1). In this study, 120-mer RNA baits
generating a 2× coverage for Varicella-Zoster Virus (VZV), a
5× coverage for Epstein-Barr virus (EBV) and Kaposi’s sarcoma-
associated Herpesvirus (KSHV), were synthetized and hybridized
with DNA extracted from a range of clinical samples including
blood, saliva, vesicle fluid, cerebrospinal fluid, and tumor cell
lines. Full-length herpes virus genomes were reconstructed at
high read depth for the 13 samples tested and generated further
studies on the structure and diversity of the viral population
(Depledge et al., 2011). Following this study, the capture of
whole genomic hybrids made it possible to study the genomic
diversity of eight new complete EBV genomes isolated from
biopsy specimens of primary nasopharyngeal carcinomas (Kwok
et al., 2014), 37 Zika virus genomes (ZIKV) samples out of
66 attempts (Metsky et al., 2017), 453 complete genomes (with
>90% genome coverage and >100-fold read depth) of different
norovirus genotypes from 509 stool samples (Brown et al.,
2016) and to achieve sufficient coverage for de novo genome
assembly and detection of single nucleotide variants of Lassa virus
(LASV) from ultra-low input samples (Matranga et al., 2014).
This approach has been also used to characterize other clinically
relevant viruses, such as hepatitis C virus (HCV) (Thomson
et al., 2016), varicella zoster virus (Depledge et al., 2014), human
herpesvirus 7 (HHV-7) (Donaldson et al., 2013, 7) and the herpes
simplex virus 1 and 2 (HSV-1 and HSV-2) (Greninger et al.,
2018). Hybrid capture associated with shotgun sequencing could
also be performed using a combination of several viral species
used as baits. Indeed, Wylie et al. (2015) developed ViroCap,
a panel of probes designed to enrich nucleic acid from 34
families of DNA and RNA viruses (190 viral genera and 337
species) that infect vertebrate hosts, except human endogenous
retrovirus. These probes were tested both on a pool of 14 clinical
samples, which tested positive for a viral infection, and on eight
samples from young children with fever, also positive for one
or more viruses. Libraries were sequenced before capture (pre-
capture) and following capture using ViroCap (post-capture).
Combining results from both experiments, 32 viruses were
detected (11 additional in the post-captured samples), including
diverse DNA and RNA viruses (with genomes ranging from 5–
161 kb) with genomic coverage >80% for 16 of the 32 genomes.
Several complete genomes were reconstructed and belonged to
Human bocavirus 1, Human parvovirus B19, human adenovirus
B (type 3), human adenovirus C (type 1), KI polyomavirus,
sapovirus, and human astrovirus 1. Finally, although ViroCap
cannot detect viral sequences that are completely novel, its design,
which includes neighbor genomes of reference sequences, allows
variants with nucleotide sequence identity as low as 58% to
be identified (Wylie et al., 2015). The same year, VirCapSeq-
VERT, a virome capture sequencing platform targeting 207 viral
taxa infecting vertebrates was described (Briese et al., 2015).
VirCapSeq-VERT allowed reduction of background human DNA
and a 100 to 10,000 fold enrichment in viral reads when
compared with other enrichment procedures such as treatment
with nucleases or RiboZero rRNA depletion (Briese et al., 2015).
In 2018, a similar approach called ViroFind was designed to
target 535 DNA and RNA viruses, which are known to infect
humans or cause zoonoses. This in-solution target enrichment
was applied to the brain biopsy samples of five patients with
progressive multifocal leukoencephalopathy (PML) (Chalkias
et al., 2018). It allowed the description of highly complex
Polyoma virus JC populations as well as the detection of large
genetic divergence among variants, with some of these mutations
conferring viral fitness advantages (Chalkias et al., 2018). Lastly,
other applications of target-enrichment sequencing have been
described, such as the study of viral genome integrations within
the human genome. This approach was powerful and efficient
to identify Merkel Cell Polyomavirus (MCPyV) insertion sites
on DNA extracted from formalin-fixed and paraffin-embedded
tissue from Merkel cell carcinoma (Duncavage et al., 2011). It
also allowed to analyze retroviral genomes integrated within host
genomic DNA in case of human T-cell leukemia virus type-1
(HTLV-1) and human immunodeficiency virus type-1 (HIV-1)
infections (Miyazato et al., 2016).
Paleomicrobiology
Paleomicrobiology is an emerging research field dedicated to the
detection, identification and characterization of microorganisms
(bacteria, viruses, and parasites) in ancient specimens.
Elucidating past infectious diseases can lead to a better
understanding of the temporal and geographical distributions
of infected individuals, the introduction of microorganisms into
human populations, the host-pathogen relationships but also the
genetic evolution of the microorganisms (Drancourt and Raoult,
2005). The main limitations of paleomicrobiological studies
concern the degradation of ancient DNA (aDNA) and the risk
of contamination by modern DNA (Riviera-Perez et al., 2016).
Target-enrichment prior to sequencing is therefore a particularly
relevant tool in this context for genomes study. The first two
studies using targeted enrichment in paleomicrobiology have
investigated genetic changes and virulence factor of Yersinia
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pestis, the causal agent of the second plague pandemics (Black
Death, 14–17th centuries) (Bos et al., 2011; Schuenemann et al.,
2011; Table 1). To this end, an array-based enrichment using
probe targeting either the full Y. pestis chromosome or pestis-
specific virulence plasmids was applied directly after the DNA
extraction from ancient bones (Schuenemann et al., 2011, 1)
and/or teeth (Bos et al., 2011; Schuenemann et al., 2011).
Using targeted DNA capture approach combined with high-
throughput sequencing, the authors reconstructed 99% of the
pPCP1 plasmid sequence (Schuenemann et al., 2011) and a
draft genome of Y. pestis (Bos et al., 2011) with the molecular
damages typically associated with aDNA. Comparisons with
modern genomes did not identify any significant genetic
variation that could explain the differences between the ancient
and modern forms of the disease (Schuenemann et al., 2011).
More recently, three other draft genomes of Y. pestis have
been recovered from individuals who died during the first
plague pandemics (the Plague of Justinian, 6–8th centuries)
in two different rural sites in southern Germany (Wagner
et al., 2014; Feldman et al., 2016). Genetic characterization
showed that these 3 drafts derived from a single Justinianic
strain which is unique and harbors novel substitutions and
structural polymorphism (Wagner et al., 2014; Feldman et al.,
2016). Finally, target enrichment sequencing also allowed the
reconstruction of new Y. pestis strains from Bronze Age
individuals (∼3,800 BP) (Spyrou et al., 2018) providing further
datas into the early stages of Y. pestis genome evolution including
on genomic characteristics supporting flea-borne transmission
in rodents or humans (Spyrou et al., 2018). Finally, target-
enrichment sequencing approaches in the paleomicrobiological
research field have not been exclusively applied to the study
of ancient plague pandemics, but have also allowed genomic
investigation of ancient Mycobacterium tuberculosis (Bos et al.,
2014), M. leprae (Schuenemann et al., 2013), Variola virus
(Duggan et al., 2016), P. falciparum (Marciniak et al., 2016),
and Treponema pallidum (Schuenemann et al., 2018) in human
remains.
CONCLUSION
Target-enrichment sequencing is an efficient approach that
allows large fragments and even entire sequences of the genome
of targeted microorganisms to be reconstructed directly from
modern and ancient complex biological samples containing a
low pathogen/host nucleic acid ratio. The information provided
by the genome can be used to explore the genetic diversity,
epidemiology, evolutionary traits, transmission networks,
host-pathogen interactions or antimicrobial resistance of the
target pathogen or its variants. The main current limitations
of democratizing target-enrichment sequencing in clinical
diagnostic laboratories are its elevated cost, the high expertise
required for library preparation and the necessary time to
generate biotinylated probes from reference genomes, which
hampers a rapid response to an emerging pathogen. Above
all, it is not suitable for the detection and characterization
of completely novel microorganisms, including viruses whose
emergence may represent one of the main threats to human
health in the near future.
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